Introduction: Gastrectomy with proper lymphadenectomy is considered the cornerstone of treatment for potentially curable gastric cancer. Stomach cancer is one of the important leading causes of cancer related death in worldwide. Annually, it was diagnosed with 9, 89,600 new cases and 7, 38,000 deaths (10% of all cancer death) in worldwide. The overall prognosis is not very favorable. However, surgery in the form of gastrectomy is the only treatment modality for a chance of long term survival as well as hope for cure. Aim of the study: Aim of the study was to find outcome of Early Postoperative Outcome of D2 Gastrectomy. Material & Methods: This prospective study was conducted at the Department of Surgical Oncology, National Institute of Cancer Research & Hospital (NICRH), Dhaka, Bangladesh from January 2019 to December 2020. A total 80 number of gastric cancer patients who were underwent gastrectomy were considered in this study. Statistical Analysis was performed with help of Epi Info (TM) 7.2.2.2. EPI INFO is a trademark of the Centers for Disease Control and Prevention (CDC). Descriptive statistical analysis was performed to calculate the means with corresponding standard deviations. Results: The mean age (mean ± SD) of the patients was 49.10±8.32 years with range 28-66 years and the median age was 48.5 years. The age group 45-54 years (50.0%) were significantly higher than other age group (Z= 3.26; p<0.001). Only 5.0% were with age between 25-34 years and 27.5% of the patients were with age ≥55 years. Thus in this study the patients with age between were in higher risk of having gastric cancer. Proportion of males (75.0%) was significantly higher than that of females (25.0%) (Z=7.07; p<0.0001). Conclusion: Surgery for gastric cancer is the only hope for cure or long term survival in the arena of multimodal management of cancers. It provides quick symptom relief by loco regional control, adds to survival of the individual, cure in case of early gastric cancer and proper staging for planning of subsequent adjuvant treatment.
| Published in | Cancer Research Journal (Volume 9, Issue 1) |
| DOI | 10.11648/j.crj.20210901.17 |
| Page(s) | 53-60 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Early Postoperative, Outcome, D2 Gastrectomy, Lymphadenectomy, Cancer
| [1] | Lin J-X, Huang C-M, Zheng C-H, Li P, Xie J-W, Wang J-B, et al. Surgical outcomes of 2041 consecutive laparoscopic gastrectomy procedures for gastric cancer: a large-scale case control study. PLoS One. 2015; 10: e0114948. |
| [2] | Badgwell B, Blum M, Estrella J, Chiang YJ, Das P, Matamoros A, et al. Predictors of survival in patients with resectable gastric cancer treated with preoperative chemo radiation therapy and gastrectomy. J Am Coll Surgeons. 2015; 221 (1): 83-90. |
| [3] | Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, et al. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol. 2016; 22 (10): 2875. |
| [4] | Chen Q-Y, Huang C-M, Lin J-X, Zheng C-H, Li P, Xie J-W, et al. Laparoscopy-assisted versus open D2 radical gastrectomy for advanced gastric cancer without serosal invasion: a case control study. World J Surg Oncol. 2012; 10: 248. |
| [5] | Park YK, Yoon HM, Kim YW, Park JY, Ryu KW, Lee YJ, et al. Laparoscopy assisted versus Open D2 distal gastrectomy for advanced gastric cancer: results from a randomized phase II multicenter clinical trial (COACT 1001). Ann Surg. 2018; 267: 638–45. |
| [6] | Degiuli, M., Sasasko, M., Ponti, A., et al. (2014) Morbidity and Mortality in Italian Gastric Cancer Study Group Randomized Clinical Trial of D1 versus Modified D2 Resection for Gastric Cancer. British Journal of Surgery, 101, 23-31. |
| [7] | Danielson, H., Kokkola, A., Kiviluoto, T., Siren, J., et al. (2007) Clinical Outcome after D1 versus D2-3 Gastrectomy for Treatment of Gastric Cancer. Scandinavian Journal of Surgery, 96, 35-40. |
| [8] | Lewis, W. G., Edwards, P., et al. (2002) D2 or Not D2? The Gastrectomy Question. Gastric Cancer, 5, 29-34. |
| [9] | Edwards, P., Blackshaw, G. R. J. C., Lewis, W. G., Barry, J. D., Allison, M. C. and Jones, D. R. B. (2004) Prospective Comparison of D1 vs. Modified D2 Gastrectomy for Carcinoma. British Journal of Cancer, 90, 1888-1892. |
| [10] | Wanebo, H. J., Kennedy, B. J., Chmiel, J., Steele, G., Winchester, D. and Osteen, R. (1993) Cancer of Stomach. A Patient Care Study by American College of Surgeons. Annals of Surgery, 218, 583-592. |
| [11] | Huang, C.-M., Lin, J.-X., Zheng, C.-H., Li, P., Xie, J.-W. And Wang, J.-B. (2011) Impact of the Number of Dissected Lymph Nodes on Survival for Gastric Cancer after Distal Subtotal Gastrectomy. Gastroenterology Research and Practice, 2011, Article ID: 476014. |
| [12] | Alfar Nafae, Raiees Ahmad, Amber Aliya, Yawar Nisar, Pervaze Salam, Imtiyaz Ahmad Surgical Science, 2016, 7, 13-26. |
| [13] | Methasate, A., Trakarnsanga, A., Akaraviputh, T., Chinsawangwathanakol, V. and Lohsiriwat, D. (2010) Lymph Node Metastasis in Gastric Cancer: Result of Modified D2 Dissection. Journal of the Medical Association of Thailand, 93, 310-317. |
| [14] | Sano, T., Sasako, M., Yamamoto, S., Nashimoto, A., Kurita, A., Hiratsuka, M., et al. (2004) Gastric Cancer Surgery: Morbidity and Mortality Results from a Prospective Randomized Controlled Trial Comparing Modified D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501. Journal of Clinical Oncology, 22, 2767-2773. |
| [15] | Kinoshita, T., Maruyama, K., Sasako, M. and Okajima, K. (1993) Treatment Results of Gastric Cancer Patients: Japanese Experience. In: Nishi, M., Ichikawa, H., Nakajima, T., Maruyama, K. and Tahara, E., Eds., Gastric Cancer, Springer, Tokyo, 319- 330. |
| [16] | Song Y., Huang J., Wang J. (2010) [Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma]. Chin J Cancer 29: 76–81. |
| [17] | Bang Y., Chung H., Xu J., Lordick F., Sawaki A., Lipatov O., Al-Sakaff N., et al. (2009) Pathological features of advanced gastric cancer (GC): Relationship to human epidermal growth factor receptor 2 (HER2) positivity in the global screening programme of the ToGA trial. J Clin Oncol 27 (215 Suppl.): abstract 4556. |
APA Style
Nabir Hossain, Ahsan Habib, Quazi Habibullah. (2021). A Prospective Study of Early Postoperative Outcome of D2 Gastrectomy: A Tertiary Hospital of Bangladesh. Cancer Research Journal, 9(1), 53-60. https://doi.org/10.11648/j.crj.20210901.17
ACS Style
Nabir Hossain; Ahsan Habib; Quazi Habibullah. A Prospective Study of Early Postoperative Outcome of D2 Gastrectomy: A Tertiary Hospital of Bangladesh. Cancer Res. J. 2021, 9(1), 53-60. doi: 10.11648/j.crj.20210901.17
AMA Style
Nabir Hossain, Ahsan Habib, Quazi Habibullah. A Prospective Study of Early Postoperative Outcome of D2 Gastrectomy: A Tertiary Hospital of Bangladesh. Cancer Res J. 2021;9(1):53-60. doi: 10.11648/j.crj.20210901.17
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.crj.20210901.17,
author = {Nabir Hossain and Ahsan Habib and Quazi Habibullah},
title = {A Prospective Study of Early Postoperative Outcome of D2 Gastrectomy: A Tertiary Hospital of Bangladesh},
journal = {Cancer Research Journal},
volume = {9},
number = {1},
pages = {53-60},
doi = {10.11648/j.crj.20210901.17},
url = {https://doi.org/10.11648/j.crj.20210901.17},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20210901.17},
abstract = {Introduction: Gastrectomy with proper lymphadenectomy is considered the cornerstone of treatment for potentially curable gastric cancer. Stomach cancer is one of the important leading causes of cancer related death in worldwide. Annually, it was diagnosed with 9, 89,600 new cases and 7, 38,000 deaths (10% of all cancer death) in worldwide. The overall prognosis is not very favorable. However, surgery in the form of gastrectomy is the only treatment modality for a chance of long term survival as well as hope for cure. Aim of the study: Aim of the study was to find outcome of Early Postoperative Outcome of D2 Gastrectomy. Material & Methods: This prospective study was conducted at the Department of Surgical Oncology, National Institute of Cancer Research & Hospital (NICRH), Dhaka, Bangladesh from January 2019 to December 2020. A total 80 number of gastric cancer patients who were underwent gastrectomy were considered in this study. Statistical Analysis was performed with help of Epi Info (TM) 7.2.2.2. EPI INFO is a trademark of the Centers for Disease Control and Prevention (CDC). Descriptive statistical analysis was performed to calculate the means with corresponding standard deviations. Results: The mean age (mean ± SD) of the patients was 49.10±8.32 years with range 28-66 years and the median age was 48.5 years. The age group 45-54 years (50.0%) were significantly higher than other age group (Z= 3.26; pConclusion: Surgery for gastric cancer is the only hope for cure or long term survival in the arena of multimodal management of cancers. It provides quick symptom relief by loco regional control, adds to survival of the individual, cure in case of early gastric cancer and proper staging for planning of subsequent adjuvant treatment.},
year = {2021}
}
TY - JOUR T1 - A Prospective Study of Early Postoperative Outcome of D2 Gastrectomy: A Tertiary Hospital of Bangladesh AU - Nabir Hossain AU - Ahsan Habib AU - Quazi Habibullah Y1 - 2021/03/10 PY - 2021 N1 - https://doi.org/10.11648/j.crj.20210901.17 DO - 10.11648/j.crj.20210901.17 T2 - Cancer Research Journal JF - Cancer Research Journal JO - Cancer Research Journal SP - 53 EP - 60 PB - Science Publishing Group SN - 2330-8214 UR - https://doi.org/10.11648/j.crj.20210901.17 AB - Introduction: Gastrectomy with proper lymphadenectomy is considered the cornerstone of treatment for potentially curable gastric cancer. Stomach cancer is one of the important leading causes of cancer related death in worldwide. Annually, it was diagnosed with 9, 89,600 new cases and 7, 38,000 deaths (10% of all cancer death) in worldwide. The overall prognosis is not very favorable. However, surgery in the form of gastrectomy is the only treatment modality for a chance of long term survival as well as hope for cure. Aim of the study: Aim of the study was to find outcome of Early Postoperative Outcome of D2 Gastrectomy. Material & Methods: This prospective study was conducted at the Department of Surgical Oncology, National Institute of Cancer Research & Hospital (NICRH), Dhaka, Bangladesh from January 2019 to December 2020. A total 80 number of gastric cancer patients who were underwent gastrectomy were considered in this study. Statistical Analysis was performed with help of Epi Info (TM) 7.2.2.2. EPI INFO is a trademark of the Centers for Disease Control and Prevention (CDC). Descriptive statistical analysis was performed to calculate the means with corresponding standard deviations. Results: The mean age (mean ± SD) of the patients was 49.10±8.32 years with range 28-66 years and the median age was 48.5 years. The age group 45-54 years (50.0%) were significantly higher than other age group (Z= 3.26; pConclusion: Surgery for gastric cancer is the only hope for cure or long term survival in the arena of multimodal management of cancers. It provides quick symptom relief by loco regional control, adds to survival of the individual, cure in case of early gastric cancer and proper staging for planning of subsequent adjuvant treatment. VL - 9 IS - 1 ER -
Information
Email: